The impact of the entry of biosimilars : evidence from Europe
Year of publication: |
July, 2017
|
---|---|
Authors: | Scott Morton, Fiona ; Stern, Ariel D. ; Stern, Scott |
Publisher: |
[Boston, MA] : Harvard Business School |
Subject: | health care | biosimilars | Biologics | pharmaceutical competition | healthcare spending | innovation | Health Care and Treatment | Spending | Market Entry and Exit | Competition | Innovation and Invention | Pharmaceutical Industry | United States | Europe | Pharmaindustrie | Pharmaceutical industry | Markteintritt | Market entry | EU-Staaten | EU countries | Innovation | USA | Gesundheitskosten | Health care costs | Arzneimittel | Pharmaceuticals | Europa | Wettbewerb | Gesundheitswesen | Health care system | Industrieforschung | Industrial research | Pharmakologie | Pharmacology | Arzneimittelmarkt | Pharmaceutical market |
Extent: | 1 Online-Ressource (circa 71 Seiten) Illustrationen |
---|---|
Series: | Working papers / Harvard Business School, Division of Research. - Boston, Mass. : Harvard Business School, ISSN 0898-7629, ZDB-ID 2276801-4. - Vol. 16, 141 |
Type of publication: | Book / Working Paper |
Type of publication (narrower categories): | Arbeitspapier ; Working Paper ; Graue Literatur ; Non-commercial literature |
Language: | English |
Source: | ECONIS - Online Catalogue of the ZBW |
-
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona, (2018)
-
Banerjee, Tannista, (2014)
-
Bayerlein, Michael, (2023)
- More ...
-
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona, (2018)
-
Will the stork return to Europe and Japan? : understanding fertility within development nations
Feyrer, James Donald, (2008)
-
Feyrer, James Donald, (2007)
- More ...